326 related articles for article (PubMed ID: 23733748)
1. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.
Braun TP; Grossberg AJ; Krasnow SM; Levasseur PR; Szumowski M; Zhu XX; Maxson JE; Knoll JG; Barnes AP; Marks DL
FASEB J; 2013 Sep; 27(9):3572-82. PubMed ID: 23733748
[TBL] [Abstract][Full Text] [Related]
2. Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle.
Braun TP; Szumowski M; Levasseur PR; Grossberg AJ; Zhu X; Agarwal A; Marks DL
PLoS One; 2014; 9(9):e106489. PubMed ID: 25254959
[TBL] [Abstract][Full Text] [Related]
3. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
6. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
8. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.
Watson ML; Baehr LM; Reichardt HM; Tuckermann JP; Bodine SC; Furlow JD
Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1210-20. PubMed ID: 22354783
[TBL] [Abstract][Full Text] [Related]
9. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
10. Knockout of USP19 Deubiquitinating Enzyme Prevents Muscle Wasting by Modulating Insulin and Glucocorticoid Signaling.
Coyne ES; Bedard N; Wykes L; Stretch C; Jammoul S; Li S; Zhang K; Sladek RS; Bathe OF; Jagoe RT; Posner BI; Wing SS
Endocrinology; 2018 Aug; 159(8):2966-2977. PubMed ID: 29901692
[TBL] [Abstract][Full Text] [Related]
11. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
13. MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms.
Parveen A; Bohnert KR; Tomaz da Silva M; Wen Y; Bhat R; Roy A; Kumar A
FASEB J; 2021 Aug; 35(8):e21821. PubMed ID: 34325487
[TBL] [Abstract][Full Text] [Related]
14. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
[TBL] [Abstract][Full Text] [Related]
15. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
Li Y; Zhang F; Modrak S; Little A; Zhang H
Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
[TBL] [Abstract][Full Text] [Related]
16. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice.
Hu Z; Wang H; Lee IH; Du J; Mitch WE
J Clin Invest; 2009 Oct; 119(10):3059-69. PubMed ID: 19759515
[TBL] [Abstract][Full Text] [Related]
17. Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia.
Wang X; Pickrell AM; Zimmers TA; Moraes CT
PLoS One; 2012; 7(3):e33426. PubMed ID: 22428048
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis.
Braun TP; Zhu X; Szumowski M; Scott GD; Grossberg AJ; Levasseur PR; Graham K; Khan S; Damaraju S; Colmers WF; Baracos VE; Marks DL
J Exp Med; 2011 Nov; 208(12):2449-63. PubMed ID: 22084407
[TBL] [Abstract][Full Text] [Related]
19. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
Puppa MJ; Gao S; Narsale AA; Carson JA
FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
